3-126988610-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 3P and 5B. PM2PP2BP4_StrongBS1_Supporting
The NM_032242.4(PLXNA1):c.17G>A(p.Arg6Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000654 in 1,543,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032242.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLXNA1 | NM_032242.4 | c.17G>A | p.Arg6Gln | missense_variant | 2/32 | ENST00000393409.3 | NP_115618.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLXNA1 | ENST00000393409.3 | c.17G>A | p.Arg6Gln | missense_variant | 2/32 | 1 | NM_032242.4 | ENSP00000377061.2 | ||
PLXNA1 | ENST00000684469.1 | c.17G>A | p.Arg6Gln | missense_variant | 2/2 | ENSP00000507976.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152240Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000760 AC: 13AN: 171092Hom.: 0 AF XY: 0.0000864 AC XY: 8AN XY: 92612
GnomAD4 exome AF: 0.0000690 AC: 96AN: 1391112Hom.: 0 Cov.: 32 AF XY: 0.0000803 AC XY: 55AN XY: 685236
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152358Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.17G>A (p.R6Q) alteration is located in exon 1 (coding exon 1) of the PLXNA1 gene. This alteration results from a G to A substitution at nucleotide position 17, causing the arginine (R) at amino acid position 6 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
PLXNA1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2024 | The PLXNA1 c.17G>A variant is predicted to result in the amino acid substitution p.Arg6Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.043% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at